102 related articles for article (PubMed ID: 8199079)
21. Immunocytochemical study of epidermal growth factor receptor, transforming growth factor alpha, and "squamous differentiation" in human endometrial carcinoma.
Santini D; Ceccarelli C; Martinelli GN; Leone O; Marabini A; Orlandi C; Mancini AM
Hum Pathol; 1994 Dec; 25(12):1319-23. PubMed ID: 7528164
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD34, alpha-smooth muscle actin and transforming growth factor-beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the cervix.
Li Q; Huang W; Zhou X
J Int Med Res; 2009; 37(2):446-54. PubMed ID: 19383239
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of condylomatous atypia and human papilloma virus antigen in cervical biopsies in 1972 and 1983.
Kock KF; Johansen P
Acta Obstet Gynecol Scand; 1987; 66(2):111-5. PubMed ID: 3039785
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix.
Nonogaki H; Fujii S; Konishi I; Nanbu Y; Ozaki S; Ishikawa Y; Mori T
Cancer; 1990 Dec; 66(12):2620-7. PubMed ID: 2249202
[TBL] [Abstract][Full Text] [Related]
25. Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia.
Smedts F; Ramaekers F; Troyanovsky S; Pruszczynski M; Robben H; Lane B; Leigh I; Plantema F; Vooijs P
Am J Pathol; 1992 Mar; 140(3):601-12. PubMed ID: 1372156
[TBL] [Abstract][Full Text] [Related]
26. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
Simpson KL; Jones A; Norman S; Holmes CH
Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.
Holm R; Skomedal H; Helland A; Kristensen G; Børresen AL; Nesland JM
J Pathol; 1993 Jan; 169(1):21-6. PubMed ID: 8433212
[TBL] [Abstract][Full Text] [Related]
28. Patterns of keratin 19 expression in normal, metaplastic, condylomatous, atrophic, dysplastic, and malignant cervical squamous epithelium.
Mittal KR; Demopoulos RI; Goswami S
Am J Clin Pathol; 1992 Oct; 98(4):419-23. PubMed ID: 1384306
[TBL] [Abstract][Full Text] [Related]
29. The Ki67+ proliferation index correlates with increased cellular retinol-binding protein-1 and the coordinated loss of plakophilin-1 and desmoplakin during progression of cervical squamous lesions.
Schmitt-Graeff A; Koeninger A; Olschewski M; Haxelmans S; Nitschke R; Bochaton-Piallat ML; Lifschitz-Mercer B; Gabbiani G; Langbein L; Czernobilsky B
Histopathology; 2007 Jul; 51(1):87-97. PubMed ID: 17593084
[TBL] [Abstract][Full Text] [Related]
30. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
[TBL] [Abstract][Full Text] [Related]
31. Expression of CAAT enhancer binding protein beta (C/EBP beta) in cervix and endometrium.
Arnett B; Soisson P; Ducatman BS; Zhang P
Mol Cancer; 2003 Apr; 2():21. PubMed ID: 12713669
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
33. Cervical condylomas show higher proliferation than do inflamed or metaplastic cervical squamous epithelium.
Mittal K; Palazzo J
Mod Pathol; 1998 Aug; 11(8):780-3. PubMed ID: 9720508
[TBL] [Abstract][Full Text] [Related]
34. Patterns of expressions of transforming growth factor and epidermal growth factor receptor in squamous cell lesions of the urinary bladder.
Tungekar MF; Linehan J
J Clin Pathol; 1998 Aug; 51(8):583-7. PubMed ID: 9828815
[TBL] [Abstract][Full Text] [Related]
35. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix.
Konishi I; Fujii S; Nonogaki H; Nanbu Y; Iwai T; Mori T
Cancer; 1991 Sep; 68(6):1340-50. PubMed ID: 1651807
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic estrogen receptors in carcinoma of the uterine cervix.
Yajima A; Yamauchi R; Wada Y; Furuhashi N; Toki T; Tase T; Oikawa N; Sato S; Takabayashi T; Ozawa N
Gynecol Obstet Invest; 1985; 20(2):103-8. PubMed ID: 4054727
[TBL] [Abstract][Full Text] [Related]
38. Expression of cytokeratins in early neoplastic epithelial lesions of the uterine cervix.
Puts JJ; Moesker O; Kenemans P; Vooijs GP; Ramaekers FC
Int J Gynecol Pathol; 1985; 4(4):300-13. PubMed ID: 2417968
[TBL] [Abstract][Full Text] [Related]
39. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
40. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
